Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6atac small nuclear 20, pseudogene (RNU6ATAC20P)
- Target
- RNU6ATAC20P
- Molecular classification
- Pseudogene, Small nuclear RNA (snRNA) pseudogene, Non-coding RNA, Other
01
Overview
RNA, U6atac small nuclear 20, pseudogene (RNU6ATAC20P) is a non-coding RNA gene classified as a pseudogene. It is one of several *U6atac small nuclear RNA* pseudogenes found in the genome; these are derived from ancient duplication and retrotransposition events of the functional U6atac snRNA gene. The canonical U6atac snRNA is a component of the minor spliceosome, which is responsible for splicing a rare class of introns in cellular pre-mRNA. As a pseudogene, RNU6ATAC20P is not believed to produce a functional RNA product, nor does it encode a protein. While some pseudogenes have acquired regulatory functions—such as being processed into small RNAs involved in gene regulation or serving as miRNA decoys—no particular function has been attributed to RNU6ATAC20P, and it is not considered a therapeutic or pharmacological target[3][5][7]. There are no drugs, disease associations, or safety issues linked to this specific pseudogene.
- Other names
- RNU6ATAC20PRNA U6atac snRNA 20 pseudogene
02
Mechanism of action
None
03
Biological functions
None specific; pseudogenes generally do not encode functional molecules, but can sometimes play regulatory roles such as acting as RNA decoys or being sources of regulatory RNAs in some contexts
04
Disease associations
None established; some pseudogenes are deregulated in cancer or may play roles in gene regulation, but there is no evidence for this specific pseudogene in disease
Beyond the preview
Go deeper on RNA, U6atac small nuclear 20, pseudogene (RNU6ATAC20P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6atac small nuclear 20, pseudogene (RNU6ATAC20P).